Congenius AG
Congenius AG is a Swiss MedTech consultancy founded in 2016 providing tailored Quality, Regulatory, eHealth, Operations, and Clinical consulting to MedTech start-ups, SMEs, and global firms, plus the QMgeniuS eQMS product.
- Company typePrivate
- Founded2016
- HeadquartersZürich, Switzerland
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Congenius AG does
Congenius AG is a privately held Swiss medical technology consultancy founded in 2016 and headquartered in Dietikon, Switzerland. The firm provides tailored consulting across five integrated excellence areas — Quality, Regulatory, eHealth, Operations, and Clinical — to global MedTech firms, established SMEs, and MedTech start-ups. Its core product is QMgeniuS, an MDR- and IVDR-compliant QMS/eQMS solution specifically designed for start-ups, delivered either as a digital document management system (built on the Simploud backbone and SharePoint) or as a paper-based QMS, validated per ISO 13485, EU MDR/IVDR, and 21 CFR Part 11. Congenius states 70 employees with an average of 15 years of MedTech industry experience per consultant, a customer base of 250, and 680 completed projects over its 10-year history.
The company monetizes primarily through professional-services engagements (project-based and retainer consulting) supplemented by an annual subscription licence for the QMgeniuS digital eQMS and paid Academy events. GTM is consultative enterprise sales driven through website demo requests, the free MinigeniuS advisory service, and Academy webinars in partnership with Health Tech Cluster Switzerland, Swiss Healthcare Startups, Sitem StartUp Club, and USI. Distribution is direct and global (Switzerland, D-A-CH, US, Canada, China, Japan), with no disclosed channel partner or reseller network.
Congenius is founder-influenced: Jörg Dogwiler founded the firm and remains President of the Board and lead of business development, while Bastian Perroset became CEO in 2024. The Board includes senior former executives from Roche, Biotronik, Philips, Ypsomed, Zimmer Biomet, and Hocoma. The firm remains privately held with no disclosed external investors, funding rounds, M&A activity, or subsidiaries.
Congenius AG firmographics
Firmographics- Name
- Congenius AG
- Legal name
- Congenius AG
- Website
- https://congenius.ch
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Congenius AG is a Swiss MedTech consultancy founded in 2016 providing tailored Quality, Regulatory, eHealth, Operations, and Clinical consulting to MedTech start-ups, SMEs, and global firms, plus the QMgeniuS eQMS product.
- Ownership category
- akta.pro rank
Congenius AG industry classification
Industry- Product category
- Medical Device Consulting
- NAICS
- Other Scientific and Technical Consulting Services (54169), Computer Systems Design Services (541512)
- akta.pro primary industry
- Quality Management Systems (QMS) & GxP Documentation (HLAGAKAD)
- akta.pro secondary industries
- Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI), Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control) (HLAGAKAL), Manufacturing Quality Assurance & GMP Compliance (batch release, deviation/CAPA, tech transfer QA) (HLAGAKAJ), Instrumentation, Controls & Automation Engineering Consulting (BPAHAIAM)
Keywords
Where Congenius AG is headquartered
LocationHeadquarters
- HQ city
- Zürich
- HQ country
- Switzerland
- HQ region
- Europe
Offices1 record
Markets served
Congenius AG business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Medical Device Consulting Services: Congenius provides tailored consulting across five excellence areas: Quality, Regulatory, eHealth, Operations, and Clinical. Projects span QMS setup, regulatory strategy, technical documentation, software lifecycle management, process validation, and clinical evaluation. Revenue is generated through billable consulting engagements scoped to each customer requirement.
- QMgeniuS eQMS Annual Licence: The digital QMgeniuS eQMS is offered on an annual licence fee model. The licence includes full support and change requests. This represents a recurring subscription revenue stream from the QMS product targeted at start-ups.
- QMgeniuS Paper-Based QMS Consulting: For customers preferring a paper-based QMS solution, Congenius charges a consultant fee for tailoring processes and implementing them according to the customer's needs. This is a one-time consulting fee model.
- Congenius Academy Training & Events: Congenius Academy delivers webinars, talks, training sessions, Q&As, and collaborative learning events across topics such as ISO 10993 biocompatibility, MDR/IVDR regulatory affairs, AI/ML in medical devices, reimbursement strategy, and design controls. Some events are free (e.g., HTCS Regulatory Q&As), others are paid. Revenue is generated through event registration fees and sponsored sessions.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | QMgeniuS eQMS (Digital) — Annual Licence |
| One time/ perpetual license | Multi-year contract | QMgeniuS Paper-Based QMS — Consultant Fee |
| Freemium | Pay-as-you-go | MinigeniuS — Free Initial Advisory |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
Congenius AG product offering
Product offeringCore offering
Congenius AG is a Swiss medical technology consultancy that provides specialized consulting services across Quality, Regulatory, eHealth, Operations, and Clinical functions for medical device, in-vitro diagnostic (IVD), and pharmaceutical companies. The firm also offers QMgeniuS, a proprietary QMS/eQMS software solution designed specifically for MedTech start-ups to manage quality and regulatory documentation. Headquartered in Dietikon, Switzerland and founded in 2016, the company has 70 employees averaging 15 years of MedTech experience.
Product overview
Congenius AG is a Swiss medical technology consultancy offering a portfolio of specialized services across five excellence areas: Quality, Regulatory, eHealth, Operations, and Clinical. Their primary product is QMgeniuS, an MDR & IVDR compliant QMS/eQMS solution specifically designed for MedTech start-ups, delivered either as a digital Document Management System (DMS) or via paper-based execution. Complementing this core software product, they provide comprehensive consulting services spanning quality management systems, regulatory affairs strategy and submissions, medical device software (SaMD/SiMD) development support, manufacturing operations optimization, and clinical affairs including evaluation and investigations. The portfolio is unified by their focus on helping MedTech companies achieve regulatory compliance and market access.
Differentiator
Problem solved
Functional benefit
Brands
- QMgeniuS: An MDR & IVDR compliant QMS / eQMS solution tailored for start-ups, offering flexible implementation to save time and money. It provides a basic framework for establishing a complete QMS according to ISO 13485.
Products and services
- Quality Management Consulting
Quantifiable outcome
- 680 successful projects completed across 10 years of existence
- +3 more outcomes
Companies that use Congenius AG
Customer profileNamed customers11 records
Segments5 records
Ideal customer profiles3 records
Congenius AG technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature2 records
Congenius AG partnerships and signals
Strategic signalPartnerships
14 partnerships are on record, tiered minor and core.
- Swiss MedTechminorSwiss MedTech is the association of Swiss medical technology, representing more than 600 companies. Founded in 2017, it represents and promotes the interests of the Swiss medical technology industry. Congenius is a member, enabling industry representation and networking.
- MedTech & Pharma Platform AssociationminorThe MedTech & Pharma Platform (MPP) connects companies from pharma, MedTech, and tech sectors to exchange knowledge and collaborate on technology and regulatory areas for combined products. Congenius participates as a member, supporting industry dialogue and combined-product expertise.
- SNV — Swiss Association for StandardizationminorSNV is the Swiss representative for global and European standardization, serving as a bridge between standardization experts and those using the standards. By partnering with SNV, Congenius joins a worldwide standardization network and shapes technical framework conditions in the MedTech industry.
- Health Tech Park Zurich-SchlierencoreHealth Tech Park Zurich-Schlieren supports Health Tech start-ups in developing companies and gaining market access. Congenius is an Official Service Partner for Quality, Regulatory Affairs, and Digital Health. The partnership aligns with Congenius's mission to support MedTech start-ups and provides a referral channel for consulting engagements.
- Swiss Healthcare StartupscoreSwiss Healthcare Startups is a non-profit organisation supporting innovative startups in the Swiss healthcare ecosystem since 2016. It provides CORTEX digital directory, partner network, and event access. Congenius collaborates on Academy events (e.g., Biocompatibility webinar) and provides expert knowledge to the startup community.
- Sitem StartUp ClubcoreThe Sitem StartUp Club (SSC), founded by sitem-insel AG, UniBE, and Insel Group in 2020, supports MedTech startups with coworking space, networking, and the MedTech Booster (MTB) acceleration program. Congenius collaborates with SSC to help develop MedTech startups into thriving businesses through workshops and consulting.
- KAPSLYminorKAPSLY enables HealthTech founders to launch successful companies faster through a network of service partners, corporates, and investors. Congenius is partnered with KAPSLY as a sponsor, helping reduce operational risks and accelerate time-to-market for HealthTech start-ups.
- BluelionminorBluelion is a Zurich-based startup incubator and non-profit organisation helping tech entrepreneurs get from 0 to 1. Congenius shares its team's expertise as one of Bluelion's experts, supporting the incubator's community of entrepreneurs.
- Zurich Chamber of CommerceminorFounded in 1873, the Zurich Chamber of Commerce represents approximately 1,100 member companies in cantons Zurich, Schaffhausen, and Zug. Congenius is a member, benefiting from industry representation, networking, and business development opportunities.
- USI Università della Svizzera italianacoreUSI is one of 12 certified public universities in Switzerland. Congenius collaborates in the creation of the eHealth Business Program — a learning program providing entrepreneurs with knowledge and skills to establish a strong position in the market and prepare for eHealth start-up growth.
- Wyss ZurichminorWyss Zurich Translational Center fosters translational projects from ETH Zurich and the University of Zurich in regenerative medicine, robotics, and medical devices/bionics. Congenius contributes expertise to support entrepreneurship and translation of science into life improvements.
- SimploudcoreSimploud is a digital partner that provides the digital backbone for Congenius's QMgeniuS e-solution. Together they deliver a lean QMS that is MDR, IVDR, and 21 CFR Part 11 compliant, specifically designed for the dynamic environment of medical device companies.
- Swiss m4m CenterminorSwiss m4m Center is a leading company in additive manufacturing within the medical device industry, with ISO 13485-certified infrastructure. Congenius partners with m4m to provide comprehensive quality and regulatory support for companies adopting additive manufacturing for innovative medical devices.
- MArS — Market Access & Pricing StrategycoreMArS specialises in market access strategies and implementation within the D-A-CH region (Germany, Austria, Switzerland), the US, and Canada. Services include reimbursement dossiers, consultation procedures, pricing negotiation with health authorities and insurance providers, health economics modelling, and stakeholder engagement. Congenius partners with MArS to provide enhanced reimbursement strategy solutions for start-up and established medical device companies.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
Congenius AG competitors and assessment
Company assessmentDirect peers
- NAMSA: Global MedTech-focused CRO and regulatory/quality consultancy spanning testing, clinical research, and regulatory strategy. Comparable in offering breadth across the five-pillar service model Congenius provides.
- Qualio: Cloud-native eQMS purpose-built for life sciences start-ups and scale-ups. Competes directly with QMgeniuS in the MedTech start-up QMS market Congenius targets.
- Greenlight Guru: MedTech-focused eQMS platform with built-in regulatory workflows and consulting partnerships. Closest competitor to Congenius's QMgeniuS product line and a direct alternative for the start-up QMS customer segment.
- Qserve Group: Dutch-headquartered MedTech regulatory, quality, and clinical consultancy offering similar services across EU MDR/IVDR, ISO 13485, FDA, and clinical evaluation. Most directly comparable competitor in size, scope, and customer base to Congenius.
- Medidee Services: Swiss-headquartered MedTech regulatory, quality, and clinical affairs consultancy. Highly comparable as a near-identical geographic and service competitor within the Swiss MedTech ecosystem.
Broad incumbents
- ICON plc: Large global CRO and clinical/regulatory services provider. Comparable on the Clinical pillar of Congenius's offering, particularly clinical investigations and medical writing for MedTech.
- MasterControl: Established life-sciences eQMS and quality management software vendor with broader enterprise footprint than QMgeniuS. Comparable as an alternative QMS platform for Congenius's regulated device clients.
- TÜV SÜD: Global testing, inspection, certification, and training organisation active across MedDevice regulatory and quality. Comparable as a large-scale incumbent Congenius competes against on enterprise certification and consulting mandates.
- BSI Group: Global standards body and certification/consulting organisation that issues ISO 13485 certification and runs MedTech training and consultancy programmes. Comparable as a larger, broader-scope incumbent in the same quality and regulatory compliance space.
Emerging players
- ETQ (Hexagon): Quality management software vendor with growing MedTech/life-sciences presence. Competes with QMgeniuS as an alternative eQMS for the same regulated customer base.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Congenius AG social profiles
Digital presenceCongenius AG compliance and trust
Trust signalCompliance4 records
Congenius AG financial estimates
Financial estimateRevenue estimate
Valuation estimate
Congenius AG leadership team
Management profileNumber of profiles
Profiles1 record
Congenius AG funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Congenius AG M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Congenius AG
What does Congenius AG do?
Congenius AG is a Swiss medical technology consultancy that provides specialized consulting services across Quality, Regulatory, eHealth, Operations, and Clinical functions for medical device, in-vitro diagnostic (IVD), and pharmaceutical companies. The firm also offers QMgeniuS, a proprietary QMS/eQMS software solution designed specifically for MedTech start-ups to manage quality and regulatory documentation. Headquartered in Dietikon, Switzerland and founded in 2016, the company has 70 employees averaging 15 years of MedTech experience.
Is Congenius AG a public or private company?
Congenius AG is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Congenius AG founded?
Congenius AG was founded in 2016. It employs 11 to 50 people.
Where is Congenius AG based?
Congenius AG is headquartered in Zürich, Switzerland, in the Europe region.
How does Congenius AG make money?
Four revenue lines are on record. Medical Device Consulting Services are the primary driver. The others are QMgeniuS eQMS Annual Licence, QMgeniuS Paper-Based QMS Consulting and congenius Academy Training & Events.
Who are Congenius AG's main competitors?
Direct peers on record are NAMSA, Qualio, Greenlight Guru, Qserve Group and Medidee Services. Broad incumbents are ICON plc, MasterControl, TÜV SÜD and BSI Group. ETQ (Hexagon) is listed as an emerging player.
Does Congenius AG have an API?
No public API is recorded for Congenius AG.
What industry is Congenius AG in?
Congenius AG's product category is Medical Device Consulting. Its primary akta.pro industry code is HLAGAKAD, Quality Management Systems (QMS) & GxP Documentation, with a secondary code of HLAGAKAI, Clinical Quality Assurance (GCP QA, TMF/QMS oversight). Its NAICS code is 54169.